Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Related posts:
Monoprice Recalls Pure Outdoor Cooking System Due to Fire Hazard (Recall Alert)March 8, 2023
Relion Battery Recalls Relion Insight Series Lithium Batteries Due to Thermal Burn and Fire HazardsMarch 1, 2023
Helly Hansen Recalls Adult Workwear Sweatshirts and Hoodies Due to Violation of Federal Flammability...March 1, 2023
Views: 263